M
OUNTAIN VIEW, Calif.--Aclara Biosciences, which makes chips for genetic analysis, drug screening, and other uses, filed to raise more than $97 million in an initial public offering, said a Reuters report. Details such as the number of shares and the expected price range of them were not included in the filing to the Securities and Exchange Commission.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.